Plasmodium Falciparum Histone Deacetylases as Novel Antimalarial Drug Targets

Loading...
Thumbnail Image
File version
Author(s)
Primary Supervisor

Andrews, Kathy

Other Supervisors

Gardiner, Donald

Editor(s)
Date
2010
Size
File type(s)
Location
License
Abstract

Histone deacetylases (HDACs) are recognised as potential drug targets for many diseases including cancer, inflammatory diseases and some parasitic diseases including malaria. In eukaryotic cells, these enzymes play an important role in transcriptional regulation through modification of chromatin structure. Inhibitors of mammalian HDAC enzymes including trichostain A and apicidin are active against P. falciparum parasites, however these compounds are not selective for malaria parasites versus normal cell lines. The aims of this study were to examine the antimalarial potential of new hydroxamate-based HDAC inhibitors and to investigate a P. falciparum HDAC, PfHDAC1, as a potential new antimalarial drug target.

Journal Title
Conference Title
Book Title
Edition
Volume
Issue
Thesis Type

Thesis (PhD Doctorate)

Degree Program

Doctor of Philosophy (PhD)

School

School of Health Science

Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement

The author owns the copyright in this thesis, unless stated otherwise.

Item Access Status

Public

Note

Journal articles have not been published here.

Access the data
Related item(s)
Subject

Histone deacetylases

Eukaryotic cells

Inflammatory diseases

Mammalian HDAC enzymes

Persistent link to this record
Citation